Wheeler Bio, Inc.

Wheeler Bio is a pioneering Contract Development and Manufacturing Organization (CDMO) focused on accelerating the discovery-to-development process for biopharmaceutical companies. Through a unique partnering model, we aim to address industry bottlenecks by facilitating smoother transitions between discovery and development phases, empowering innovators to bring novel antibody and antibody-like therapeutics to market with precision, speed, and optimized cost without ever compromising quality. Wheeler Bio specializes in mammalian cell line and process development, GLP Tox material supply, and CGMP clinical supply, leveraging our Portable CMC® platform to streamline the pathway from innovation to clinical trials. Our approach has been purposefully designed to reduce lifecycle challenges, enhance efficiency, and foster lasting collaborations within the biopharma industry.